News & Press: Latest News

"Pulse of the Industry" Details Med Tech Opportunities and Challenges

Tuesday, October 2, 2012  
Share |

Ernst and Young's 2012 "Pulse of the Industry" was released todayand detailed the current environment for medical technology innovators. The report noted that increasingly medtech innovators are adapting to an outcomes-focused health care system, and that new challenges will be to address "new customer-empowering and information-leveraging technologies."

Some of their findings included:

  • Revenue for non-conglomerates in the US and Europe totaled US$319.9 billion in 2011, a 6% increase from 2010
  • Between June 30, 2011 and June 30, 2012, US and European public medtech companies raised $27.4 billion, though 80% of all capital raised was in the form of debt by a relatively small number of companies
  • M&A activity among US and European medical technology companies in the year ending June 30, 2012 had a total value of US$35 billion.

Building on the FDA user fee reauthorization and efforts to repeal the medical device tax, MDMA continues to focus on supporting an ecosystem where medical technology innovators can thrive.